section 8
on 05 Jun 2020
Last Applicant/ Owned by
Route de la Corniche 4
1066 Epalinges
CH
Serial Number
85510388 filed on 06th Jan 2012
Registration Number
4405437 registered on 24th Sep 2013
Correspondent Address
DAVID A JACKSON
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Advertising; business management; business administration assistance; providing office functions, providing business analysis and research services Food supplements for medical purposes; pharmaceutical, veterinary and sanitary preparations, namely, anti-inflammatory drugs, inhibitors of cell signalling, anti-cancer drugs, antiinfectives and anti-viral drugs; dietetic substances adapted for medicaRead More
Food supplements for medical purposes; pharmaceutical, veterinary and sanitary preparations, namely, anti-inflammatory drugs, inhibitors of cell signalling, anti-cancer drugs, antiinfectives and anti-viral drugs; dietetic substances adapted for medical use, namely, food for babies; adjuvants for medical purposes; proteins for medical purposes; biological preparations for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; pharmaceutical preparations for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; chemical preparations for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular and rheumatologic diseases; ferments for pharmaceutical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; hormones for medical purposes; medicinal infusions for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; chemical reagents for medical or veterinary purposes, excluding anti-viral and HIV pharmaceutical preparations and substances
Advertising; business management; business administration assistance; providing office functions, providing business analysis and research services
Scientific and technological services and research, namely, pharmaceutical research in particular drug discovery, and design, excluding pharmaceuticals in the HIV and anti-viral therapeutic areas; providing pharmaceutical analysis and research services, excluding pharmaceuticals in the HIV and anti-viral therapeutic areas; design and development of computer hardware and software
No 85510388
No Service Mark
No 3325-3-001
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 05th Jun 2020 | CANCELLED SEC. 8 (6-YR) |
| 24th Sep 2018 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 24th Sep 2013 | REGISTERED-PRINCIPAL REGISTER |
| 20th Aug 2013 | OPPOSITION TERMINATED NO. 999999 |
| 20th Aug 2013 | OPPOSITION DISMISSED NO. 999999 |
| 20th Aug 2013 | TTAB RELEASE CASE TO TRADEMARKS |
| 06th Aug 2013 | PAPER RECEIVED |
| 29th Jul 2013 | PAPER RECEIVED |
| 07th Jun 2013 | OPPOSITION INSTITUTED NO. 999999 |
| 03rd Jan 2013 | EXTENSION OF TIME TO OPPOSE RECEIVED |
